JP2024001073A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024001073A5 JP2024001073A5 JP2023165289A JP2023165289A JP2024001073A5 JP 2024001073 A5 JP2024001073 A5 JP 2024001073A5 JP 2023165289 A JP2023165289 A JP 2023165289A JP 2023165289 A JP2023165289 A JP 2023165289A JP 2024001073 A5 JP2024001073 A5 JP 2024001073A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023165289A JP7849340B2 (ja) | 2017-10-24 | 2023-09-27 | 抗グリコｍｕｃ１抗体およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2017/058036 WO2019083506A1 (en) | 2017-10-24 | 2017-10-24 | ANTI-GLYCO-MUC1 ANTIBODIES AND USES THEREOF |
| JP2020543460A JP7358367B2 (ja) | 2017-10-24 | 2017-10-24 | 抗グリコｍｕｃ１抗体およびその使用 |
| JP2023165289A JP7849340B2 (ja) | 2017-10-24 | 2023-09-27 | 抗グリコｍｕｃ１抗体およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543460A Division JP7358367B2 (ja) | 2017-10-24 | 2017-10-24 | 抗グリコｍｕｃ１抗体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024001073A JP2024001073A (ja) | 2024-01-09 |
| JP2024001073A5 true JP2024001073A5 (enExample) | 2024-04-24 |
| JP7849340B2 JP7849340B2 (ja) | 2026-04-21 |
Family
ID=66247577
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543460A Active JP7358367B2 (ja) | 2017-10-24 | 2017-10-24 | 抗グリコｍｕｃ１抗体およびその使用 |
| JP2023165289A Active JP7849340B2 (ja) | 2017-10-24 | 2023-09-27 | 抗グリコｍｕｃ１抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543460A Active JP7358367B2 (ja) | 2017-10-24 | 2017-10-24 | 抗グリコｍｕｃ１抗体およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3700936A4 (enExample) |
| JP (2) | JP7358367B2 (enExample) |
| KR (2) | KR102608763B1 (enExample) |
| CN (1) | CN111479828B (enExample) |
| AU (1) | AU2017436815B2 (enExample) |
| BR (1) | BR112020008001A2 (enExample) |
| CA (1) | CA3078812A1 (enExample) |
| IL (1) | IL274202A (enExample) |
| MX (1) | MX2020004220A (enExample) |
| WO (1) | WO2019083506A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020008001A2 (pt) * | 2017-10-24 | 2020-10-20 | Go Therapeutics, Inc. | anticorpo anti-glico-muc1 ou fragmento de ligação de antígeno, proteína de fusão, receptor de antígeno quimérico, conjugado de anticorpo-fármaco, ácido nucleico, vetor, célula hospedeira, composição farmacêutica, e, métodos de tratar câncer e de detectar câncer em uma amostra biológica. |
| US11970546B2 (en) * | 2020-07-31 | 2024-04-30 | R.P. Scherer Technologies, Llc | Antibody specific for Mucin-1 and methods of use thereof |
| JP2024534148A (ja) * | 2021-08-27 | 2024-09-18 | ペプトロン インコーポレイテッド | 新規抗ｍｕｃ１抗体およびその用途 |
| WO2023121448A1 (en) * | 2021-12-21 | 2023-06-29 | Merus N.V. | Binding domains against cancer-associated muc1 |
| CN115068610B (zh) * | 2022-01-27 | 2024-04-16 | 中国农业大学 | 抑制乳腺癌细胞中muc1表达的物质在降低抗乳腺癌药物耐药性中的应用 |
| CN120882753A (zh) * | 2023-04-13 | 2025-10-31 | 江苏恒瑞医药股份有限公司 | 特异性结合egfr和muc1的抗原结合分子、其药物偶联物及其医药用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001075110A2 (en) * | 2000-03-30 | 2001-10-11 | Dyax Corp. | Mucin-1 specific binding members and methods of use thereof |
| DE10303664A1 (de) * | 2003-01-23 | 2004-08-12 | Nemod Immuntherapie Ag | Erkennungsmoleküle zur Behandlung und Detektion von Tumoren |
| AU2007304590A1 (en) * | 2006-10-04 | 2008-04-10 | Cancer Research Technology Limited | Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies |
| EP2014302A1 (en) * | 2007-07-12 | 2009-01-14 | Institut Curie | An antibody specific for the Tn antigen for the treatment of cancer |
| JP5532401B2 (ja) * | 2007-12-05 | 2014-06-25 | 協和発酵キリン株式会社 | ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体 |
| CN102264765B (zh) * | 2008-10-28 | 2016-01-20 | 盐野义制药株式会社 | 抗muc1抗体 |
| EP2281844A1 (en) * | 2009-07-31 | 2011-02-09 | Glycotope GmbH | MUC 1 antibodies |
| US10208125B2 (en) * | 2013-07-15 | 2019-02-19 | University of Pittsburgh—of the Commonwealth System of Higher Education | Anti-mucin 1 binding agents and uses thereof |
| WO2015120180A1 (en) * | 2014-02-05 | 2015-08-13 | The University Of Chicago | Chimeric antigen receptors recognizing cancer-specific tn glycopeptide variants |
| US10239950B2 (en) * | 2014-04-28 | 2019-03-26 | Medicinal Chemistry Pharmaceuticals, Co., Ltd. | Anti-MUC1 antibody or antigen-binding fragment thereof and uses thereof |
| BR112020008001A2 (pt) | 2017-10-24 | 2020-10-20 | Go Therapeutics, Inc. | anticorpo anti-glico-muc1 ou fragmento de ligação de antígeno, proteína de fusão, receptor de antígeno quimérico, conjugado de anticorpo-fármaco, ácido nucleico, vetor, célula hospedeira, composição farmacêutica, e, métodos de tratar câncer e de detectar câncer em uma amostra biológica. |
-
2017
- 2017-10-24 BR BR112020008001-2A patent/BR112020008001A2/pt unknown
- 2017-10-24 MX MX2020004220A patent/MX2020004220A/es unknown
- 2017-10-24 EP EP17929557.1A patent/EP3700936A4/en active Pending
- 2017-10-24 WO PCT/US2017/058036 patent/WO2019083506A1/en not_active Ceased
- 2017-10-24 CA CA3078812A patent/CA3078812A1/en active Pending
- 2017-10-24 KR KR1020207014390A patent/KR102608763B1/ko active Active
- 2017-10-24 JP JP2020543460A patent/JP7358367B2/ja active Active
- 2017-10-24 AU AU2017436815A patent/AU2017436815B2/en active Active
- 2017-10-24 KR KR1020237040745A patent/KR102832078B1/ko active Active
- 2017-10-24 CN CN201780097773.8A patent/CN111479828B/zh active Active
-
2020
- 2020-04-23 IL IL274202A patent/IL274202A/en unknown
-
2023
- 2023-09-27 JP JP2023165289A patent/JP7849340B2/ja active Active